TNFSF11 and osteoporosis: Recent studies have found that JAK inhibitors impeded osteoclast activity and osteoporosis via modulating the RANKL and reactive oxygen species signaling pathways, which indicated the possible role of LMT-28 on JAK-related signaling in osteoclasts [35, 36].